{
    "id": "a6d48e99-4411-4724-8372-b01692a5dff7",
    "indications": "ambrisentan tablets indicated treatment pulmonary arterial hypertension ( pah ) ( group 1 ) adult patients : improve exercise ability delay worsening . establishing effectiveness included predominantly patients functional class ii iii symptoms etiologies idiopathic heritable pah ( 60 % ) pah associated connective tissue diseases ( 34 % ) .",
    "contraindications": "• initiate treatment 5 mg daily ( 2.1 ) . • titrate 4-week intervals needed tolerated ( 2.1 ) . • split , crush , chew tablets ( 2.1 ) .",
    "warningsAndPrecautions": "ambrisentan tablets 5 mg pale pink , film-coated , square shaped convex tablets debossed “ ” one side “ 5 ” side supplied follows : bottles 30 ndc 59651-494-30 ambrisentan tablets 10 mg deep pink , film-coated , oval shaped convex tablets debossed “ ” one side “ 10 ” side supplied follows : bottles 30 ndc 59651-495-30 store 20° 25°c ( 68° 77°f ) ; excursions permitted 15° 30°c ( 59° 86°f ) [ usp controlled room temperature ] . store ambrisentan tablets original packaging .",
    "adverseReactions": "pregnancy ( 4.1 ) idiopathic pulmonary fibrosis ( 4.2 )",
    "ingredients": [
        {
            "name": "AMBRISENTAN",
            "code": "HW6NV07QEC"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "FD&C RED NO. 40",
            "code": "WZB9127XOA"
        },
        {
            "name": "LECITHIN, SOYBEAN",
            "code": "1DI56QDM62"
        },
        {
            "name": "POLYETHYLENE GLYCOL 3350",
            "code": "G2M7P15E5P"
        },
        {
            "name": "POLYVINYL ALCOHOL, UNSPECIFIED",
            "code": "532B59J990"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        }
    ],
    "organization": "Aurobindo Pharma Limited",
    "name": "ambrisentan",
    "effectiveTime": "20250421",
    "indications_original": "Ambrisentan tablets are indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) in adult patients:\n                  \n                  \n                     To improve exercise ability and delay clinical worsening.\n                  \n                  Studies establishing effectiveness included predominantly patients with WHO Functional Class II to III symptoms and etiologies of idiopathic or heritable PAH (60%) or PAH associated with connective tissue diseases (34%).",
    "contraindications_original": "• Initiate treatment at 5 mg once daily ( 2.1 ). • Titrate at 4-week intervals as needed and tolerated ( 2.1 ). • Do not split, crush, or chew tablets ( 2.1 ).",
    "warningsAndPrecautions_original": "Ambrisentan Tablets 5 mg are pale pink, film-coated, square shaped convex tablets debossed with “AS” on one side and “5” on other side and are supplied as follows:\n                  \n                  Bottles of 30                                       NDC   59651-494-30\n                  \n                  \n                     Ambrisentan Tablets 10 mg are deep pink, film-coated, oval shaped convex tablets debossed with “AS” on one side and “10” on other side and are supplied as follows:\n                  \n                  Bottles of 30                                       NDC   59651-495-30\n                  \n                  Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Store ambrisentan tablets in its original packaging.",
    "adverseReactions_original": "Pregnancy ( 4.1 ) Idiopathic Pulmonary Fibrosis ( 4.2 )"
}